Cytogenetic and molecular genetic aspects of eosinophilic leukaemias

British Journal of Haematology

Volumn 122, Issue 2, 2003, Pages 173-179

  Bain, Barbara J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Cytogenetics; Eosinophilic leukaemia; Idiopathic hypereosinophilic syndrome; Imatinib; Molecular genetics; Oncogenes

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

BONE MARROW CELL; CELL PROLIFERATION; CHROMOSOME 8P; CHRONIC DISEASE; CHRONIC LEUKEMIA; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; EOSINOPHILIA; EOSINOPHILIC LEUKEMIA; GENE FUSION; GENE REARRANGEMENT; HUMAN; IDIOPATHIC DISEASE; KARYOTYPE; LEUKEMIA; LEUKEMOGENESIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

CYTOGENETIC ANALYSIS; DIAGNOSIS, DIFFERENTIAL; ENZYME INHIBITORS; EOSINOPHILS; HUMANS; HYPEREOSINOPHILIC SYNDROME; MUTATION; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PYRIMIDINES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, FIBROBLAST GROWTH FACTOR; TRANSLOCATION, GENETIC;

EID: 0038487039     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04458.x     Document Type: Review

References (75)

1. Al-Obaidi, M.J., Rymes, N., White, P., Pomfret, M., Smith, H., Starczynski, J. & Johnson, R. (2002) A fourth case of 8p11 myeloproliferative disorder transforming to B-lineage acute lymphoblastic leukaemia. Acta Haematologica, 107, 98-100.
2. Apperley, J., Gardembas, M., Melo, J., Russell-Jones, R., Bain, B.J., Baxter, J., Chase, A., Chessels, J.M., Colombat, M., Dearden, C., Dimitrijevic, S., Mahon, F.-X., Marin, D., Nikolava, Z., Olavarria, E., Silberman, S., Schultheis, B., Cross, N.C.P. & Goldman, J.M. (2002) Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. New England Journal of Medicine, 347, 481-487.
3. Ault, O., Cortes, J., Koller, C., Kaled, E.S. & Kantarjian, H. (2002) Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate. Leukemia Research, 26, 881-884.
4. Bain, B.J. (2002) An overview of translocation-associated oncogenesis in the chronic myeloid leukaemias. Acta Haematologica, 107, 57-63.
5. Bain, B., Pierre, R., Imbert, M., Vardiman, J.W., Brunning, R.D. & Flandrin, C. (2001) Chronic eosinophilic leukaemia and the hypereosinophilic syndrome. In: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (ed. by E.S. Jaffe, N.L. Harris, H. Stein & J.W. Vardiman), pp. 29-31. IARC Press, Lyon.
6. Baxter, E.J., Kulkarni, S., Vizmanos, J.-L., Jaju, R., Martinelli, G., Testoni, N., Hughes, G., Salamanchuk, Z., Calasanz, M.J., Lahortiga, I., Pocock, C.F., Dang, R., Fidler, C., Wainscoat, J.S., Boultwood, J. & Cross, N.C.P. (2003) Novel translocations that disrupt the platelet-derived growth factor receptor β (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. British Journal of Haematology, 120, 251-256.
7. Bigoni, R., Cuneo, A., Roberti, M.G., Milani, R., Bardi, A., Cavazzini, F., Minotto. C. & Castoldi, G. (2000) Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome. Haematologica, 85, 486-491.
8. Bitran, J.D., Rowley, J.D., Plapp, F., Golomb, H.M. & Ultmann, J.E. (1977) Chromosomal aneuploidy in a patient with hypereosinophilic syndrome: evidence for a malignant disease. American Journal of Medicine, 68, 1010-1014.
9. Brigaudeau, C., Liozon, E., Bernard, P., Trimoreau, F., Bordessoule, D. & Praloran, V. (1996) Deletion of chromosome 20q associated with hypereosinophilic syndrome: a report of two cases. Cancer Genetics and Cytogenetics, 87, 82-84.
10. Britobabapulle, F., Butler, T.A., Secker-Walker, L. & Goldman, J.M. (1997) Eosinophilic myelodysplastic syndrome: an entity to be distinguished from the idiopathic hypereosinophilic syndrome. Blood, 90. 285b.
11. Cabrol, C. (1979) Chromosomal anomaly in eosinophilic leukemia. New England Journal of Medicine, 301, 439.
12. Chan, L.C., Kwong, Y.L., Lie, A.K.W. & Ching, L.M. (1994) A case of Philadelphia-negative M-BCR rearranged eosinophilic leukaemia with trisomy 8 localized by in situ hybridization. Leukemia, 8, 195-198.
13. Cools, J., DeAngelo. D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., Kutok, J., Clark, J., Galisnsky, I., Griffin, J.D., Cross, N.C.P., Tefferi, A., Malone, J., Alam, R., Schrier, S.L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantarjian, H., Marynen, P., Coutre, S.E., Stone, R. & Gilliland, D.G. (2003) A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine, 348, 1201-1214.
14. Cortes, J.E., Ault, P., Koller, C., Thomas, D., Ferrajoli, A., Wierda, W., Rios, M.B., Letvak, L. & Kantarjian, H. (2002) Treatment of hypereosinophilic syndrome (HES) with imatinib mesylate. Blood, 100, 71a.
15. Darbyshire, P.J., Shortland, D. & Swansbury, G.J. (1987) A myeloproliferative disease in two infants associated with eosinophilia and a chromosome t(1;5) translocation. British Journal of Haematology, 66, 483-486.
16. Duell, T., Mittelmuller, J., Schmetzer, H.M., Kold, H.J. & Wilmanns, W. (1997) Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32). Cancer Genetics and Cytogenetics, 94, 91-94.
17. Ellman, L., Hammond, D. & Atkins, L. (1979) Eosinophilia, chloromas and a chromosome abnormality in a patient with a myeloproliferative syndrome. Cancer, 43, 2410-2413.
18. Fioretos, T., Panagopoulos, J., Larsen, C., Swedin, A., Billström, R., Isaksson, M., Strömbeck, B., Olofsson, T., Mitelman, F. & Johansson, B. (2001) Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene with BCR but not ABL. Genes, Chromosomes and Cancer, 32, 302-310.
19. Forrest, D.L., Horsman, D.E., Jensen, C.L., Berry, B.R., Dalal, B.I., Barnett, M.J. & Nantel, S.H. (1998) Myelodysplastic syndrome with hypereosinophilia and a nonrandom chromosomal abnormality dic(1;7): confirmation of eosinophil clonal Evolvement by fluorescence in situ hybridization. Cancer Genetics and Cytogenetics, 107, 65-68.
20. Gleich, G.J., Leiferman, K.M., Pardanani, A., Tefferi, A. & Butterfield, J.H. (2002) Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet, 359, 1577-1578.
21. Goffman, T.E., Mulvihill, J.J., Carney, D.N., Triche, T.J. & Whang-Peng, J. (1983) Fatal hypereosinophilia with chromosome 15q- in a patient with multiple primary and familial neoplasms. Cancer Genetics and Cytogenetics, 8, 197-202.
22. Gohć, K.O., Ho, F.S., Tso, S.C. & Ma, J. (1985) Is hypereosinophilic syndrome a malignant disease? Cancer, 55, 2395-2399.
23. Goldman, J.M., Najfeld, V. & Th'ng, K.H. (1975) Agar culture and chromosome analysis in eosinophilic leukaemia. Journal of Clinical Pathology, 28, 956-961.
24. Gotić, M., Radošević-Radojković, N., Ludoški, M., Spasic, P., Basara, N., Avramović, D., Bosković, D. & Rolović. Z. (1994) Eosinophilic leukemia with chromosomal aberration t(5;12)(q31;q13): an evidence of the existence of chronic eosinophilic leukemia as a distinct myeloproliferative entity. British Journal of Haematology, 87, 168.
25. Gotlib, J., Malone, J.M., DeAngelo, D.J., Stone, R.M., Gilliland, D.G., Clark, J., Tefferi, A., Alam, R., Schrier, S.L. & Coutre, S.E. (2002) Imatinib mesylate (Gleevec™) induces rapid and complete hematologic remissions in patients with idiopathic hypereosinophilic syndrome (HES) without evidence of BCR-ABL or activating mutations in C-KIT and platelet-derived growth factor receptor-beta (PDGFRβ). Blood, 100, 798a.
26. Grainger, J.D., Will, A.M. & Steven, R.F. (2002) Cultured autografting for juvenile myelomonocytic leukaemia. British Journal of Haematology. 117, 477-479.
27. Granjo, E., Lima, M., Lopes, J.M., Dória, S., Orfâo, A., Ying, S., Barata, L.T., Miranda, M., Cross, N.C.P. & Bain, B.J. (2002) Chronic eosinophilic leukaemia presenting with erythroderma. mild eosinophilia and hyper-IgE; clinical, immunological and cytogenetic features and therapeutic approach: a case report. Acta Haematologica, 107, 108-112.
28. Gupta, R., Knight, C. & Bain, B.J. (2002) Receptor tyrosine kinase mutations in myeloid neoplasms. British Journal of Haematology, 117, 489-508.
29. Hild, F. & Fonatsch, C. (1990) Cytogenetic peculiarities in chronic myelogenous leukemia, Cancer Genetics and Cytogenetics, 47, 197-217.
30. Huang, C.S., Gomez, G.A., Kohno, S.I., Sokal, J.E. & Sandberg, A.A. (1979) Chromosomes and causation of human cancer and leukemia. XXXIV. A case of 'hypereosinophilic syndrome' with unusual cytogenetic findings in a chloroma, terminating in blastic transformation and CNS leukemia. Cancer, 44, 1284-1289.
31. Humphrey, M.J., Hutter, J.J. & Tom, W.W. (1981) Hypereosinophilia in a monosomy 7 myeloproliferative disorder in childhood. American Journal of Hematology, 11, 107-110.
32. Imai, Y., Yasuhara, S., Hanafusa, N., Ohsaka, A., Enokihara, H., Tomizuka, H., Sonoyama, M., Miura, Y.S., Tohda, S., Nara, N. & Takahashi, A. (1996) Clonal involvement of eosinophils in therapy-related myelodysplastic syndrome with eosinophilia, translocation t(1;7) and lung cancer. British Journal of Haematology, 95, 710-714.
33. Jani, K., Kempski, H.M. & Reeves, B.R. (1994) A case of myelodysplasia with eosinophilia having a translocation t(5;12) (q31;q13). British Journal of Haematology, 87, 57-60.
34. 1positive cells. Lancet, ii, 1340.
35. Kiossoglou, K.A., Mitus, W.J. & Dameshek, W. (1966) Cytogenetic studies in the chronic myeloproliferative syndrome. Blood, 28, 241-252.
36. Kobayashi, H., Kitano, K., Shimodaira, S., Ishida, F., Saito, H., Sonoyama, M., Enokihara, H. & Furuta, S. (1993) Eosinophilia in myelodysplastic syndrome with a (12;21)(q23;q22) translocation. Cancer Genetics and Cytogenetics, 68, 95-98.
37. Kook, H., Cho, D., Noh, H.-Y., Kim, S.-Y., Kim, H.-J., Choi, I.-S., Ryang, D.-W., Ma. J.S. & Hwang, T.J. (2002) Chronic eosinophilic leukemia with unique chromosomal abnormality. add(8)(p23), in a 14-month girl: treatment with imatinib mesylate. Blood, 100, 344b.
38. Lepretre, S., Jardin, F., Buchonnet, G., Lenain, P., Stamatoullas, A., Kupfer, I., Courville, P., Callat, M.-P., Contentin, N., Bastard, C. & Tilly, H. (2002) Eosinophilic leukaemia associated with t(2;5)(p23;q31). Cancer Genetics and Cytogenetics, 133, 164-167.
39. Lönnqvist, B., Gahrton, G., Erikson, P., Friberg, K. & Zech, L. (1979) Isochromosome 17 in a patient with a myeloproliferative disorder terminating in eosinophilic leukemia. Acta Medica Scandinavica, 206, 321-325.
40. Luciano, L., Catalano, L., Sarrantonio, C., Guerriero, A., Califano, C. & Rotoli, B. (1999) αIFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5). Haematologica, 84, 651-653.
41. Ma, S.K., Wong, K.F., Chan, J.K. & Kwong, Y.L. (1995) Refractory cytopenia with t(1;7),+8 abnormality and dysplastic eosmophils showing intranuclear Charcot-Leyden crystals: a fluorescence in situ hybridization study. British Journal of Haematology, 90, 216-218.
42. Macdonald, D., Reiter, A. & Cross, N.C.P. (2002) The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematologica, 107, 101-112.
43. Magnusson, M.K., Brown, K.E., Krueger, L.A., Arthur, D.C., Barrett, J. & Dunbar, K.E. (2000) Rabaptin-5, a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia. Blood, 96, 692a.
44. Malbrain, M.L.N.G., van den Berghe, H. & Zachée, P. (1996) Further evidence for the clonal nature of the idiopathic hypereosinophilic syndromes: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. British Journal of Haematology, 92, 176-183.
45. Marinone, G., Rossi. G. & Verzura, P. (1983) Eosinophilic blast crisis in a case of chronic myeloid leukaemia. British Journal of Haematology, 55, 251-256.
46. Michel, G., Thuret, I., Capodano, A.M., Scheiner, C., Guitard, A.M., Mozziconacci, M.J., Fossat, C. & Perrimond, H. (1991) Myelofibrosis in a child suffering from a hypereosinophilic syndrome with trisomy 8: response to corticotherapy. Medical and Pediatric Oncology, 19, 62-65.
47. Mitelman, F., Panani, A. & Brandt, L. (1975) Isochromosome 17 in a case of eosinophilic leukaemia. An abnormality common to eosinophilic and neutrophilic cells. Scandinavian Journal of Haematology, 14, 308-312.
48. Mitter, N.S. & Weiskopf, R.W. (1987) Unusual chromosome 7 aberrations in a case of eosinophilic myeloproliferative syndrome. Cancer Genetics and Cytogenetics, 26, 209-212.
49. Needleman, S.W., Mane, S.M., Gutheil, J.C., Kapil, V., Heyman, M.R. & Testa, J.R. (1990) Hypereosinophilic syndrome with evolution to myeloproliferative disorder: temporal relationship to loss of Y chromosome and c-N-ras activation. Hematological Pathology, 4, 149-155.
50. Nolasco, I., Carvalho, S. & Parreira, A. (2002) Rapid and complete response to imatinib mesylate (STI-571) in a patient with idiopathic hypereosmophilia. Blood, 100, 346b.
51. Oliver, J.W., Deol, I., Morgan, D.L. & Tonk, V.S. (1998) Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with unique chromosomal abnormality. Cancer Genetics and Cytogenetics, 107, 111-117.
52. Pardanani, A., Reeder, T., Porrata, L., Witzig, T., Li, C.-Y. & Tefferi, A. (2002) Imatinib therapy for eosinophilie disorders. Blood, 100, 800a.
53. Parreira, L., Tavares de Castro, J., Hibbin, J.A., Marsh, J.C.W., Marcus, R.E., Babapulle, V.B., Spry, C.J.F., Goldman, J.M. & Catovsky, D. (1986) Chromosome and cell culture studies in eosinophilic leukaemia. British Journal of Haematology, 62, 659-669.
54. Presti, C., Ryan, T. & Armstrong, W.F. (1987) Two dimensional and Doppler eehocardiographic findings in hypereosinophilic syndrome. American Heart Journal, 114, 172-175.
55. Quiquandon, I., Claisse, J.F., Capiod, J.C., Delobel, J. & Prin, L. (1995) α-interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission. Blood. 85, 2284-2285.
56. Ribeiro, I., Carvalho, I.R., Fontes, M., Lima, F., Mator, R., Anderson, B.A. & Uva, L. (1993) Eosinophilic leukaemia with trisomy 8 and double gammopathy. Journal of Clinical Pathology, 48, 672-673.
57. Rioux, J.D., Stone, V.A., Daly, M.J., Cargill, M., Green, T., Nguyen, H., Nutman, T., Zimmerman, P.A., Tucker, M.A., Hudson, T., Goldstein, A.M., Lander, E. & Lin, A.Y. (1998) Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-33. American Journal of Human Genetics, 63, 1086-1094.
58. Ross, F.M., Hamilton, M., Cook, M.K. & Irving, J.B. (1987) A myelodysplastic syndrome with eosinophilia associated with a break in the short arm of chromosome 16. Leukemia, 1, 680-681.
59. Roy, S., Szer, J., Campbell, L.J. & Juneja, S. (2002) Sequential transformation of t(8;13) related disease: a case report. Acta Haematologica, 107, 95-97.
60. Sato, H., Danbara, M., Tamura, M. & Morita, M. (1994) Eosinophilic leukaemia with a t(2;5)(p23;q35) translocation. British Journal of Haematology, 87, 404-406.
61. Schaller, J.L. & Burkland, G.A. (2001) Rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate. http://www.medscape.com/viewarticle/408170 (accessed 1 February 2003). Med Gen Med 2001, 3, 9.
62. Severino, S.A., Pane, E., Anghel, G., Ruscio, C., Pewtti, N., Della Seta, R. & Majolino, I. (2002) Glivec (STI 571) in idiopathic hypereosinophilic syndrome (HES) resistant to conventional treatment. Hematology Journal, 3, 307.
63. Shanske, A.L., Kalman, A. & Grunwald, H. (1996) A myeloproliferative disorder with eosinophilia associated with a unique translocation (3:5). British Journal of Haematology, 95, 524-526.
64. da Silva, M.A.P., Heerema, N., Schwenk, G.R. & Hoffman, R. (1988) Evidence for the clonal nature of hypereosinophilic syndrome. Cancer Genetics and Cytogenetics, 32, 109-115.
65. Spiers, A.S.D., Bain, B.J. & Turner, J.E. (1977) The peripheral blood in chronic granulocytic leukaemia. Scandinavian Journal of Haematology, 18, 25-38.
66. Steer, E.J. & Cross, N.C.P. (2002) Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor beta. Acta Haematologica, 107, 113-122.
67. Stockdill, G., Hartley, S.E. & Allan, N.C. (1980) Eosinophilic leukaemia in association with a double Philadelphia chromosome. Postgraduate Medical Journal, 56, 268-270.
68. Suzuki, S., Chiba, K., Toyoshima, N., Kurosawa, M., Hashino, S., Musashi, M. & Asaka, M. (2001) Chronic eosinophilic leukemia with t(6;11)(q27:q23) translocation. Annals of Hematology, 80, 553-556.
69. Viniou, N., Yataganas, X., Abazis, D., Paterakis, G., Vavourakis, S., Stamatopoulos, K., Matzourani, M., Loukopoulos, D. & Pangalos, C. (1995) Hypereosinophilia associated with monosomy 7. Cancer Genetics and Cytogenetics. 80, 68-71.
70. Weide, R., Rieder, H., Mehraein, Y., Wolf, M., Kaiser, U., Seifart, U., Görg, C. & Havemann, K. (1997) Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. British Journal of Haematology, 96, 117-123.
71. 1-negative eosinophilic leukemia with trisomy 8: case report and review of cytogenetic studies. Scandinavian Journal of Haematology, 18, 413-420.
72. Wolz, D.E., Granato, J.E., Giles, H.R., Marks, S.M. & Grill, H.P. (1993) A unique chromosomal abnormality in idiopathic hypereosinophilic syndrome presenting with cardiac involvement. American Heart Journal, 126, 246-248.
73. Yakushijin, K., Murayama, T., Mizuno, I., Sada, A., Koizumi, T. & Imoto, S. (2001) Chronic eosinophilic leukemia with unique chromosomal abnormality, t(5;12)(q33:q22). American Journal of Hematology, 68, 301-302.
74. Yamada, O., Kitahara, K., Imamura, K., Ozasa, H., Okada, M. & Mizoguchi, H. (1998) Clinical and cytogenetic remission induced by interferon-α in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation. American Journal of Hematology, 58, 137-141.
75. Yoo, T.J., Orman, S.V., Patil, S.R., Dorminey, C., Needleman, S., Rajtora, D., Graves, N., Ackerman, L. & Taylor, W.W. (1984) Evolution to eosmophilic leukemia with a t(5;11) translocation in a patient with idiopathic hypereosinophilic syndrome. Cancer Genetics and Cytogenetics, 11, 389-394.